A biochemist with an international reputation for expertise in the fields of glycobiology and glycan analysis, Pauline M. Rudd heads the GlycoSciences Research Group at the National Institute for Bioprocessing Research and Training (NIBRT) in Ireland and is NIBRT Professor of Glycoproteomics and Glycobiology at University College Dublin (UCD). Her research focuses on the design, development, and optimization of bioprocesses for the safe and economic manufacture of biopharmaceuticals. Applying glycomics technology to the analysis of blood serum and targeted proteins from patients with cancer and other illnesses, Dr. Rudd and her research team have developed strategies for changing glycans into clinical markers in the diagnosis and treatment of metastatic breast, lung, ovarian, and gastric cancers, as well as generating greater insight into the underlying molecular mechanisms of the studied diseases. A graduate of the Westfield College, University of London, she qualified for the Licentiate of the Royal Institute of Chemistry in 1967 and earned a Ph.D. in glycobiology in 1995 at The Open University. She was a founding scientist of the London-based Wessex Biochemicals (later Sigma London), where she was a senior chemist from 1964 to 1969. After joining the Glycobiology Institute at Oxford University in the early 1980s, she was appointed a senior research fellow and head of the Glycoimmunnology Group in 1996 and was subsequently named an Oxford research lecturer, then a reader in glycobiology. In 2006, when her research team relocated to the Conway Institute at UCD, she assumed her present position and also became a visiting investigator in Singapore’s A*STAR (Agency for Science, Technology, and Research) Bioprocessing Technology Institute. Dr. Rudd has been a visiting research associate at the Scripps Research Institute in California, a visiting professor of biochemistry at Shanghai Medical University, a visiting scientist at Ben-Gurion University of the Negev in Israel, and Erskine Visiting Fellow at Canterbury University in Christchurch, New Zealand. Currently a visiting professor at St. George’s Hospital in London and an adjunct professor at Northeastern University in Boston, the National University of Ireland in Galway, and Trinity College, Dublin, she is a fellow of the Royal Society of Medicine. Her numerous awards include the Templeton/American Scientific Affiliation Prize for Public Understanding of Science, the James Gregory Medal given by ISCAST (Institute for the Study of Christianity in an Age of Science and Technology), Agilent Technologies’ Thought Leader Award, and the Waters Global Innovation Award. She was given an M.A. from Oxford in 1998 and an honorary degree from the University of Gothenburg last year. Dr. Rudd has published more than 250 papers in scientific journals and volumes of collected works.